Dorsey & Whitney Trust CO LLC Raises Position in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)

Revance Therapeutics (NASDAQ:RVNC – Get Rating) posted its earnings results on Tuesday. The biopharmaceutical company reported ($0.74) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.75) by $0.01, Briefing.com reports. Revance Therapeutics had a negative return on equity of 786.70% and a negative net margin of 268.87%. The firm had revenue of […]

Related Keywords

Hong Kong ,Tobin Schilke ,Dustins Sjuts ,Money Concepts Capital Corp ,Morgan Stanley ,Advisor Group Holdings Inc ,Tower Research Capital ,Securities Exchange Commission ,Hong Kong Ltd ,Barclays ,Life Insurance Co ,Revance Therapeutics Inc ,Needham Company ,Wells Fargo Company ,Revance Therapeutics ,Get Rating ,President Dustin ,Exchange Commission ,Concepts Capital Corp ,Group Holdings ,Kong Ltd ,Research Capital ,Revance Therapeutics Daily ,Nasdaq Rvnc ,Rvnc ,Medical ,Earnings ,